These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6443772)

  • 1. Experience with cefsulodin therapy for lower respiratory tract infections caused by Pseudomonas aeruginosa in adults without cystic fibrosis or granulocytopenia.
    Nichols L; Gudmundsson S; Maki DG
    Rev Infect Dis; 1984; 6 Suppl 3():S711-20. PubMed ID: 6443772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.
    Caplan DB; Buchanan CN
    Rev Infect Dis; 1984; 6 Suppl 3():S705-10. PubMed ID: 6443771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
    Nichols L; Maki DG
    Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of urinary tract infections due to Pseudomonas aeruginosa with cefsulodin.
    Elder HA; Roy I
    Rev Infect Dis; 1984; 6 Suppl 3():S734-43. PubMed ID: 6443774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefsulodin treatment for serious Pseudomonas aeruginosa infections.
    Routman A; Van Manen W; Haddad R; Pollock B; Holmes B; Mogabgab WJ
    J Int Med Res; 1986; 14(5):242-53. PubMed ID: 3770290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefsulodin therapy for infections due to Pseudomonas aeruginosa in patients with burns.
    Heimbach DM
    Rev Infect Dis; 1984; 6 Suppl 3():S744-50. PubMed ID: 6443775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefsulodin therapy for osteomyelitis due to Pseudomonas aeruginosa.
    Pottage JC; Karakusis PH; Trenholme GM
    Rev Infect Dis; 1984; 6 Suppl 3():S728-33. PubMed ID: 6443773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefsulodin for the treatment of Pseudomonas infections--a study comparing cefsulodin and ticarcillin.
    van der Meer JW; Matze-van der Lans A; Mattie H
    Neth J Med; 1989 Jun; 34(5-6):233-42. PubMed ID: 2671757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of cefsulodin and other agents against Pseudomonas aeruginosa.
    Neu HC; Scully BE
    Rev Infect Dis; 1984; 6 Suppl 3():S667-77. PubMed ID: 6443768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pulmonary Pseudomonas aeruginosa infection in cystic fibrosis with cefsulodin.
    Møller NE; Koch C; Vesterhauge S; Jensen K
    Scand J Infect Dis; 1982; 14(3):207-11. PubMed ID: 6815787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory and clinical studies on cefsulodin (author's transl)].
    Kumasaka Y; Nakahata H; Endo K; Sasaki K; Matsuhashi A; Narita S; Imamura K; Takebe K; Masaki N; Tamura T
    Jpn J Antibiot; 1981 Oct; 34(10):1416-21. PubMed ID: 6460884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of cefmenoxime and cefsulodin in the treatment of complicated urinary tract infections caused by Pseudomonas aeruginosa.
    Doi T; Nishiura T; Deguchi K; Kondo M
    Chemotherapy; 1986; 32(3):299-304. PubMed ID: 3458567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefsulodin sodium therapy in cystic fibrosis patients.
    Cabezudo I; Thompson RL; Selden RF; Guenthner SH; Wenzel RP
    Antimicrob Agents Chemother; 1984 Jan; 25(1):4-6. PubMed ID: 6422844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pharmacokinetic study of parenteral administration of cefsulodin in pediatric patients in Japan.
    Nishimura T; Fujii R
    Rev Infect Dis; 1984; 6 Suppl 3():S751-8. PubMed ID: 6571339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefsulodin.
    Wright DB
    Drug Intell Clin Pharm; 1986 Nov; 20(11):845-9. PubMed ID: 3536385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefsulodin in treatment of Pseudomonas urinary tract infection in patients with spinal cord injury. Comparison with aminoglycosides.
    Montgomerie JZ; Morrow JW; Canawati HN; Gilmore DS; Graham IE; Ibraham MZ
    Urology; 1986 Nov; 28(5):446-50. PubMed ID: 3787915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.